Kraig Biocraft Laboratories and Warwick Mills Sign Strategic Joint Development Agreement
October 21 2013 - 6:05AM
Marketwired
Kraig Biocraft Laboratories and Warwick Mills Sign Strategic Joint
Development Agreement
Joint Intellectual Property Agreement Covers the Collaborative
Development of Spider Silk Based Textiles
LANSING, MI--(Marketwired - Oct 21, 2013) - Kraig Biocraft
Laboratories, Inc. (OTCQB: KBLB) ("Company"), the leading developer
of advanced spider silk based fibers, and Warwick Mills, Inc.
("Warwick"), a leader in the engineering and development of
advanced technical textiles and other protective materials, jointly
announced today that they have signed a collaborative development
agreement concerning the development and commercialization of
advanced textiles utilizing Kraig's Monster Silk™ recombinant
spider silk technology.
Under terms of the agreement, the two companies will jointly
develop innovative textile products based on Kraig's Monster Silk™
fibers. Under the terms of the agreement, the two companies
will jointly own textile product related intellectual property
which is developed as a result of the collaboration.
Joint development will initially focus on Monster Silk™ weaving,
testing and near term applications. The companies believe that
this collaborative relationship will help expedite the
commercialization of Monster Silk™ and future spider silk based
technical fibers.
"This collaborative undertaking represents a huge step forward
in our commercialization efforts. The pairing of Kraig's
spider silk technology with Warwick's world-class technical
textiles applications engineering and weaving abilities is a bold
move which we believe will enhance and accelerate the penetration
of spider silk into technical textile markets," said Kraig CEO and
founder, Kim K. Thompson.
"Warwick Mills is recognized for engineering technical textiles
with protective applications and its ability to bridge the gaps
between innovative technologies and market integration. Their
global reputation is built on the foundation of innovation and
performance. I believe the joint development agreement is an
important milestone and that Warwick's impressive capabilities
makes them an ideal bridge builder between Kraig's expertise in
spider silk technologies and the capturing of market share in the
technical textiles arena," concluded Thompson.
"Warwick is looking forward to developing new textiles in
cooperation with Kraig Biocraft Laboratories, and its Monster Silk™
technology. Spider silk fibers are a powerful new
technological approach to potentially opening up new application
and markets," stated Charles Howland, President of Warwick.
"The future of textiles will continue to be driven by innovation
and we believe that our textile engineering capabilities and
Kraig's fibers can change the game in some important
applications. These technologies could potentially result in
higher performance textiles which would enable very advanced safety
and military equipment. This collaborative agreement is a big
step forward in the development of exciting new textiles with
potential applications for the technical textiles and protective
textiles marketplace," concluded Howland.
About Warwick Mills
For the past century, Warwick Mills
(http://www.warwickmills.com) has been a leader in the engineering
of technical textiles for protective applications. Warwick develops
and integrates complex fiber composites for the most challenging
safety applications. Its cooperative development strategy relies on
its core technologies in technical textiles, custom adhesives, and
performance coatings, from research and development to testing and
full-scale manufacturing. This strategy ensures customer confidence
for every challenge.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
Ben Hansel Hansel Capital, LLC. (720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024